Skip to main content
Premium Trial:

Request an Annual Quote

Clarient, Definiens Partner on Image Analysis for Cancer Biomarkers

NEW YORK (GenomeWeb News) – Imaging company Definiens and the cancer treatment technology company Clarient have agreed to co-develop tools for evaluating cancer biomarkers, Clarient said today.
Under the terms of the five-year agreement, the companies will develop a series of image analysis tools that Clarient will use in its internal research programs and will also offer through its PathSite customer web portal.
The analysis tools will evaluate quantitative biomarkers that predict cancer treatment response to targeted therapies, the companies said.
Clarient processes tissue samples for biomarkers for clinical use and for biopharmaceutical development, and then converts these into high-resolution digital images that are managed and analyzed with the PathSite web portal.
Clarient Chief Medical Officer Ken Bloom said that image analysis tools are “essential” to personalized medicine. “Many of the assays in development assess several intracellular processes simultaneously, and it is critical we develop algorithms that localize and quantify key markers,” he explained.
"The partnership with Clarient will allow us to access the clinical marketplace, allowing both companies to commercialize translational medicine applications,” said Gregg Westerbeck, Definiens VP, in a statement.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.